Value of panel reactive antibodies (PRA) as a guide to the treatment of hyperimmunized patients in renal transplantation

  • Conference paper
Transplant International Official Journal of the European Society for Organ Transplantation

Abstract

Patient presensitization represents a considerable problem in candidacy for renal transplantation. While it is well known that hyperimmunized patients-panel reactive antibody (PRA) higher than 60% — create difficulties in donor matching and have a worse outcome than non-hyperimmunized patients, less information is available on patients with an intermediate degree of sensitization (30–60%). In order to evaluate how graft outcome relates to such degrees of sensitization, 241 consecutive transplanted patients were divided into two groups on the basis of their previous year’s PRA peak: group A, PRA 0–29%; group B, PRA 30–60%. Group A showed a significantly better survival both in the first year (90% vs 79%, P<0.05) and in the third year (82% vs 64%, P < 0.01). However, detailed analysis of group B demonstrated that some parameters may significantly influence graft outcome: (1) better compatibility on locus DR; (2) a primary kidney transplant; (3) a dialysis duration of less than 6 months; and (4) the prophylactic use of anti-lymphocyte globulin (ALG).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
GBP 19.95
Price includes VAT (United Kingdom)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
GBP 35.99
Price includes VAT (United Kingdom)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
GBP 44.99
Price includes VAT (United Kingdom)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Appleton DR (1988) Analysis of data in nephrology I. Choosing the correct statistical test: dichotomous variables. Nephrol Dial Transplant 3:91–94

    PubMed  CAS  Google Scholar 

  2. Claas FHJ, de Waal LP, Beelen J, Reekers P, Berg-Loonen PVD, de Gast E, D’Amaro J, Persijn GG, Zantvoort F, van Rood JJ (1990) Transplantation of highly sensitized patients on the basis of acceptable HLA-A and B mismatches. In: Terasaki P (ed) Clinical transplant 1989. UCLA Tissue Ty** Laboratory, Los Angeles, pp 185–190

    Google Scholar 

  3. Gore SM (1983) Graft survival after renal transplantation: agenda for analysis. Kidney Int 24:516–525

    Article  PubMed  CAS  Google Scholar 

  4. Grimm PC, Sinai Trieman L, Sekiya NM (1990) Effect of recombinant human erythropoietin on HLA sensitization and cell mediated immunity. Kidney Int 38:12–15

    Article  PubMed  CAS  Google Scholar 

  5. Iwachi Y, Cecka JM, Terasaki PI (1989) The transfusion effect. In: Terasaki P (ed) Clinical Transplant 1988. UCLA Tissue Ty** Laboratory, Los Angeles, pp 283–292

    Google Scholar 

  6. Lundgren G, Groth CG, Albrechtsen D (1986) HLA-matching and pre transplant blood transfusion in cadaveric renal transplantation — a changing picture with cyclosporine. Lancet 2: 66–69

    Article  PubMed  CAS  Google Scholar 

  7. Opelz G (1987) Improved kidney graft survival in non-transfused recipients. Transplant Proc 19:149–152

    PubMed  CAS  Google Scholar 

  8. Rankin GW, Wang X, Terasaki P (1991) Sensitization to kidney transplant. In: Terasaki P (ed), Clinical Transplant 1990. UCLA Tissue Ty** Laboratory, Los Angeles, pp 417–424

    Google Scholar 

  9. Sanfilippo F, Vaughn WK, LeFor WM, Spees EK (1986) Multivariate analysis of risk factors in cadaver donor kidney transplantation. Transplantation 42:28–34

    Article  PubMed  CAS  Google Scholar 

  10. Stefoni S, Nanni Costa A, Buscaroli A, Coli L, Feliciangeli G, Mosconi G, Scolari MP, Iannelli S, Borgnino LC, Bonomini V (1991) Cellular immunology in regular dialysis: a biological model for biocompatibility evaluation. Nephrol Dial Transplant 6[Suppl2]:4–9

    PubMed  Google Scholar 

  11. Tufveson G, Geerlings W, Brunner FP, Brynger H, Dykes SR, Ehrich JHH, Fassbinder W, Rizzoni G, Selwood NH, Wing AJ (1990) Combined report on regular dialysis and transplantation in Europe, XIX, 1988. Nephrol Dial Transplant 4 [Suppl 2]: 5–32

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Buscaroli, A. et al. (1992). Value of panel reactive antibodies (PRA) as a guide to the treatment of hyperimmunized patients in renal transplantation. In: Kootstra, G., Opelz, G., Buurman, W.A., van Hooff, J.P., MacMaster, P., Wallwork, J. (eds) Transplant International Official Journal of the European Society for Organ Transplantation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77423-2_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77423-2_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-55342-7

  • Online ISBN: 978-3-642-77423-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Navigation